Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1081-1087

  Smith, Raymond P ^a   Baltch, Aldona L ^a,b   Michelsen, Phyllis B ^a   Ritz, William J ^a   Alteri, Richard ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN;

ANALYTIC METHOD; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; CALCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; LEGIONELLA PNEUMOPHILA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ALGORITHMS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; HUMANS; KINETICS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MICROBIAL SENSITIVITY TESTS;

EID: 0037417047     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1081-1087.2003     Document Type: Article

References (23)

1. Brunden, M. N., B. H. Yagi, M. S, Lajiness, and G. E. Zurenko. 1991. Estimating the postantibiotic effect: a two-phase mathematical model. J. Pharmacokin. et Biopharm. 19:457-468.
2. Bundtzen, R. W., A. U. Gerber, D. L. Cohn, and W. A. Craig. 1981. Postantibiotic suppression of bacterial growth. Rev. Infect. Dis. 3:28-37.
3. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
4. Craig, W. A. 1993. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J. Antimicrob. Agents Chemother. 31(Suppl. D):149-158.
5. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-12.
6. Dubois, J., and C. St. Pierre. 2000. Comparative in-vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. J. Antimicrob. Chemother. 45(Suppl. 1):41-46.
7. Eagle, H. 1949. The recovery of bacteria from the toxic effects of penicillin. J. Clin. Investig. 28:832-836.
8. Edelstein, P. H., M. A. C. Edelstein, J. Weidenfeld, and M. B. Dorr. 1990. In vitro activity of sparfloxacin (CI-978, At-4140) for clinical legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 34:2122-2127.
9. Edelstein, P. H., M. A. Edelstein, J. Ren, R. Polzer, and R. P. Gladue. 1996. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 40:314-319.
10. Gómez-Lus, R., F. Adrián, R. del Campo, P. Gómez-Lus, S. Sánchez, C. García, and M. C. Rubio. 2001. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. Internat. J. Antimicrob. Agents 18:49-54.
11. Jason, A. C., F. M. MacKenzie, D. Jason, and I. M. Gould. 1994. Automatic procedures for measuring post-antibiotic effect and determining random errors. J. Antimicrob. Chemother. 34:669-678.
12. Liebers, D. M., A. L. Baltch, R. P. Smith, M. C. Hammer, and J. V. Conroy. 1989. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. J. Antimicrob. Chemother. 23:37-41.
13. MacKenzie, F. M., and I. M. Gould. 1993. The post-antibiotic effect. J. Antimicrob. Chemother. 32:519-537.
14. MacKenzie, F. M., I. M. Gould, D. G. Chapman, and D. Jason. 1994. Comparison of methodologies used in assessing the postantibiotic effect. J. Antimicrob. Chemother. 34:223-230.
15. Martin, S. J., and S. L. Pendland. 1998. Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone, and in combination, against Legionella pneumophila. J. Antimicrob. Chemother. 41:643-648.
16. Meng, X., C. H. Nightingale, and K. R. Sweeney. 1991. Quantification of in-vitro post-antibiotic effect based on the mean recovery-time. I. Theoretical perspectives and a practical procedure. J. Antimicrob. Chemother. 28:505-514.
17. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard MT-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Smith, R. P., A. L. Baltch, M. Franke, W. Hioe, W. Ritz, and P. Michelsen. 1997. Effect of levofloxacin, erythromycin or rifampin pretreatment on growth of Legionella pneumophila in human monocytes. J. Antimicrob. Chemother. 40:673-678.
19. Stuart, A., and J. K. Ord. 1991, Kendall's advanced theory of statistics, vol. 2, p. 707-708. Oxford University Press, New York, N.Y.
20. Stuart, A., and J. K. Ord. 1991. Kendall's advanced theory of statistics, vol.2, p. 1101-1153, 1161. Oxford University Press, New York, N.Y.
21. Vogelman, B. S., and W. A. Craig. 1985. Postantibiotic effects. J. Antimicrob. Chemother. 15:37-46.
22. Wilson, D. A., and G. N. Rolinson. 1979. The recovery period following exposure of bacteria to penicillins. Chemotherapy 25:14-22.
23. Zhanel, G. G., D. J. Hoban, and G. K. M. Harding. 1991. The postantibiotic effect: a review of in vitro and in vivo data. DICP Ann. Pharmacother. 25:153-163.